Paid Clinical Trials in York, PA
As of June 2026, 109 paid clinical trials are recruiting in York, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
York offers studies at sites including Cancer Care Associates of York for conditions such as Breast Cancer, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Chronic Lymphocytic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in York
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in York
York has approximately 109 recruiting research studies across a wide range of therapeutic areas. Pennsylvania hosts UPenn's Perelman School of Medicine and Children's Hospital of Philadelphia — pioneers in CAR-T cell therapy — alongside UPMC, Thomas Jefferson University, and Penn State Hershey.
Top Research Study Locations in York
Researchers run research studies in York, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cancer Care Associates of York | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 27 |
| WellSpan Health-York Cancer Center | Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 25 |
| UPMC Memorial | Breast Cancer, Extensive Stage Lung Small Cell Carcinoma, Prostate Adenocarcinoma | 18 |
| WellSpan Health-York Hospital | Stage IV Lung Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Stage IIIB Lung Cancer AJCC v8 | 15 |
| WellSpan Health | Acute Ischemic Stroke, Atrial Fibrillation, Diastolic Heart Failure | 7 |
| Wellspan York Hospital | Pulmonary Embolism, Coronary Arterial Disease (CAD), Coronary Artery Disease | 4 |
| WellSpan Oncology Research | Carcinoma, Non-Small-Cell Lung, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Non-Small Cell Lung Cancer (NSCLC) | 3 |
| Heart and Vascular Research at WellSpan Health | Atherosclerosis, Cardiovascular Diseases, Coronary Artery Disease | 2 |
| WellSpan York Cancer Center | Advanced Malignant Neoplasm, Advanced Solid Tumor, Breast Cancer | 2 |
| York Hospital | Atrial Fibrillation, Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries | 2 |
| Ability x Ottobock.care | Lower Extremity, Pareses | 1 |
| Cancer Care Associates Of York ( Site 0005) | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
| Cancer Care Associates Of York ( Site 0063) | Breast Neoplasms | 1 |
| Cancer Care Associates Of York ( Site 0174) | Lymphoma, Large B-Cell, Diffuse | 1 |
| Cancer Care Associates Of York ( Site 9517) | Triple-Negative Breast Cancer | 1 |
| Cancer Care Associates Of York /ID# 266143 | Non Small Cell Lung Cancer | 1 |
| Cancer Care Associates Of York /ID# 270971 | Non-Small Cell Lung Cancer | 1 |
| Cancer Care Associates of York (site 206) | Adenoid Cystic Carcinoma, Any Solid Tumors Progressed After a Prior Immunotherapy, Esophageal Cancer | 1 |
| Cancer Care Associates of York, Inc. | Breast Cancer | 1 |
| Cancer Care Associates of York, Inc. - 1113 | Non Small Cell Lung Cancer | 1 |
| Cancer Care Association of York | Small Cell Lung Cancer | 1 |
| Local Institution - 0264 | Relapsed or Refractory Multiple Myeloma | 1 |
| MD@Home | Pharmacogenomic Testing for Medication Management | 1 |
| OSS Health | Degenerative Disc Disease | 1 |
| OSS Health Powder Mill | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in York (2026)
Recruiting trials in York grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (76 active studies)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · Phase 3 · Incyte Corporation
Cardiovascular (11 active studies)
Neurology & pain (2 active studies)
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
- Stroke Thrombectomy and Aneurysm Registry · Medical University of South Carolina
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in York
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Stage IV Lung Cancer AJCC v8 (6 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Lymphocytic Leukemia (4 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Head and Neck Squamous Cell Carcinoma (4 active studies). Recruiting Head and Neck Squamous Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in York
- NRG Oncology
- AstraZeneca
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Tempus AI
Local regulations and guidelines
Clinical trials in Pennsylvania are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Pennsylvania research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in York. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in York
Hipa.ai aggregates every recruiting study in York from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in York?
There are approximately 109 recruiting clinical trials in York, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in York pay participants?
Most recruiting trials in York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in York?
The most common conditions under active study in York include Breast Cancer (7), Stage IV Lung Cancer AJCC v8 (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Chronic Lymphocytic Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in York?
Recruiting research sites in York include Cancer Care Associates of York, WellSpan Health-York Cancer Center, UPMC Memorial, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in York right now?
The largest active categories in York are Cancer & tumors (76), Cardiovascular (11), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.